Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Methods × 90 days × Clear all

Phase

Phase NA 59 Phase 3 3 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Specimen Handling 268 pembrolizumab 236 Magnetic Resonance Spectroscopy 211 Carboplatin 167 Biopsy 157 Nivolumab 140 Cyclophosphamide 135 Cisplatin 135 Paclitaxel 117 Radiotherapy 102 Gemcitabine 99 Bevacizumab 95 durvalumab 84 venetoclax 80 Rituximab 75 Oxaliplatin 74 Dexamethasone 72 Fluorouracil 69 fludarabine 63 atezolizumab 63 Prednisone 63 Ipilimumab 63 Docetaxel 63 Capecitabine 62 Cytarabine 59 olaparib 58 Radiosurgery 58 Radiation 58 Doxorubicin 58 Etoposide 53

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07507825 2026-04-02

VHAG

First People's Hospital of Hangzhou

Phase 2 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡